BioBanking as the central tool for translational medicine CTM issue 2013
Abstract The impact of mapping the human proteome: Globally, the health care organizations are under resource and cost constrains due to the increasing number of patients that are due to a fast increase of the 65+ age group requiring extensive medical hospitalization and treatments. Hospitals worldw...
Main Author: | György Marko‐Varga |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-12-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1186/2001-1326-2-4 |
Similar Items
-
Tumor biobanks in translational medicine
by: Botti Gerardo, et al.
Published: (2012-10-01) -
CTM and QFD analysis: Framework for fintech adoption priority in commercial banks.
by: Donghoon Kang, et al.
Published: (2023-01-01) -
CTM and QFD analysis: Framework for fintech adoption priority in commercial banks
by: Donghoon Kang, et al.
Published: (2023-01-01) -
The Multispecialistic da Vinci European BioBank
by: Giordana Marcon, et al.
Published: (2014-11-01) -
Collaborative Transportation Management (CTM): an innovative tool to improve supply chains
by: Vanina Macowski Durski Silva, et al.
Published: (2010-06-01)